CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation-Reference-Cited by-同舟云学术

CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation

Published:2023-10 Issue:10 Volume:13 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Li Shijia¹²,Ge Jianrong¹,Zhou Shiyuan¹²,Zhu Wenjuan¹²,Han Yue¹²^ORCID,Chen Suning¹²,Xue Shengli¹²,Wang Ying¹²,Qiu Huiying¹²,Wu Xiaojin¹²^ORCID,Wu Depei¹²

Affiliation:

1. National Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou China

2. Collaborative Innovation Center of Hematology Institute of Blood and Marrow Transplantation, Soochow University Suzhou China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Jiangsu Provincial Key Research and Development Program

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1459

Reference11 articles.

1. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

2. Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

3. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

4. Association between an Impaired Bone Marrow Vascular Microenvironment and Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation